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Abstract
Objectives Duration of delayed graft function (DGF) and length of hospital stay (LOS) are outcomes of interest in an era that
warrants increased efficacy of transplant care whereas renal allografts originate increasingly from marginal donors. While earlier
studies investigate the predictive capability of a single renal scintigraphy, this study focuses on the value for both DGF duration
and LOS of consecutively performed scintigraphies.
Methods From 2011 to 2014, renal transplant recipients referred for a Tc-99m MAG3 renal scintigraphy were included in a
single-center retrospective study. Primary endpoints were DGF duration and LOS. Both the first (≤ 3 days) and second scintig-
raphies (3–7 days after transplantation) were analyzed using a 4-grade qualitative scale and quantitative indices (TFS, cTER,
MUC10, average upslope).
Results We evaluated 200 first and 108 (54%) consecutively performed scintigraphies. The Kaplan-Meier curves for DGF
duration and qualitative grading of the first and second scintigraphy showed significant differences between the grades
(p < 0.01). The Kaplan-Meier curve for the delta grades between these procedures (lower, equal, or higher grade) did not show
significant differences (p = 0.18). Multivariate analysis showed a significant association between the qualitative grades, from the
first and second scintigraphy, and DGF duration, HR 1.8 (1.4–2.2, p < 0.01) and 2.8 (1.8–4.3, p < 0.01), respectively.
Conclusions Qualitative grades of single renal scintigraphies, performed within 7 days after transplantation, can be used to make
a reliable image-guided decision on the need for dialysis and to predict LOS. A consecutive renal scintigraphy, however, did not
show an additional value in the assessment of DGF.
Key Points
• Post-transplant renal scintigraphy procedures provide information to predict delayed graft function duration and length of
hospital stay.
• Performing two consecutive renal scintigraphy procedures within 1 week after transplantation does not strengthen the predic-
tion of delayed graft function duration and length of hospital stay.
• Single renal scintigraphy procedures can be used to provide clinicians and patients with a reliable indication of the need for
dialysis after transplantation and the expected duration of hospitalization.
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Abbreviations
DBD Donation after brain death
DCD Donation after circulatory
death
DGF Delayed graft function
IGF Immediate graft function
LOS Length of hospital stay
PNF Primary non-function
SGF Slow graft function
Introduction
The duration of delayed graft function (DGF) and the length
of hospital stay (LOS) are outcomes of interest in an era that
warrants increased efficacy of transplant care whereas renal
allografts originate increasingly from marginal donors, being
allografts from extended criteria and donation after circulatory
death (DCD) donors.
DGF describes the failure of the renal transplant to function
immediately after transplantation [1]. DGF is associated with
renal allograft failure in the first year after donation after brain
death (DBD) transplantation; however, allografts with DGF still
provide survival benefit compared to maintenance dialysis [2].
Moreover, DGF is associated with a higher incidence of biopsy-
proven acute rejection and increased LOS [3]. The current trend
of using marginal donors is associated with more DGF, longer
hospital stay, and subsequently higher transplant-related costs
[4–6]. Predicting the duration of DGF and LOS provides clini-
cians with the opportunity to optimize timing of renal biopsies
and post-transplant dialysis. For this purpose, research focus
has been on urinary and blood biomarkers for DGF, such as
urinary tissue inhibitor of metalloproteinases-2 (TIMP-2), and
quantitative/qualitative renal scintigraphy indices [7, 8].
Renal scintigraphy is an imaging biomarker of renal func-
tion, reflecting perfusion, reabsorption, and excretion. It may
help predicting DGF and LOS [9, 10]. Results of renal scin-
tigraphy can be interpreted qualitatively, differentiating in six-
(Heaf and Iversen grading scale) or in four-curve types, and
quantitatively, using several time-activity indices [11–16].
Several studies showed promising results for the use of renal
scintigraphy to predict the course of DGF; however, these
studies did not adjust for clinical variables associated with
DGF [13, 17–20].Moreover, previous studies focused primar-
ily on the qualitative and quantitative interpretation of renal
scintigraphy parameters from single procedures, whereas cli-
nicians may focus more on consecutively performed imaging.
In this center, Technetium-99m mercaptoacetyltriglycine
(Tc-99mMAG3) renal scintigraphies were performed consec-
utively in the first week after transplantation in all patients
with ongoing DGF, according to a standard post-transplant
protocol. The present study was initiated to determine if two
consecutive renal scintigraphies improved the prediction of
DGF and LOS.
Materials and methods
Study design and participants
We studied all patients receiving a renal transplant at the
Leiden University Medical Center, between 2011 and 2014,
who underwent a Tc-99m MAG3 renal scintigraphy within
3 days after transplantation. These patients are all part of a
larger dual-center retrospective cohort, resulting in an earlier
publication focusing on the predictive value of a single renal
scintigraphy for the duration of DGF > 7 days after transplan-
tation [21]. Patients were not included in case of receiving a
dual renal transplant or both renal and pancreas transplants,
and when under 18 years of age at the moment of transplan-
tation. All clinical data for this study were retrieved from our
national transplant research database, the Dutch Organ
Transplant Registry (NOTR). Missing data and information
on possible peri- and post-operative complications was re-
trieved by screening patients’ charts retrospectively. Patient
data were processed and electronically stored according to
the Declaration of Helsinki Ethical principles for medical re-
search involving human subjects, and approval for this study
was given by the Leiden University Medical Center ethics
committee. The clinical and research activities being reported
are consistent with the Principles of the Declaration of
Istanbul as outlined in the “Declaration of Istanbul on Organ
Trafficking and Transplant Tourism.”
Outcome assessment
We defined DGF as the need for dialysis after transplantation
(dialysis-based DGF) and as the failure of serum creatinine to
decrease with ≥ 10%/day during 3 consecutive days (function-
al DGF), which is in accordance with the majority of studies
on DGF [22]. Based on these definitions, we described early
transplant function using four groups, namely immediate graft
function (IGF), a serum creatinine decrease of ≥ 10%/day dur-
ing 3 consecutive days or no need for dialysis; slow graft
function (SGF), DGF between day 3–6 after transplantation;
delayed graft function (DGF), DGF for more than 7 days after
transplantation; primary non-function (PNF), immediate graft
failure with the need of dialysis. We defined LOS as the num-
ber of days between transplantation and initial discharge.
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Clinical covariates
The following covariates were examined: (i) recipient factors
(gender; age (years); body mass index (BMI, in kg/m2), dia-
betes mellitus, duration of pre-transplant dialysis (months));
(ii) donor factors (age (years), living (un)related (L(U)RD))
donation, DCD, DBD; (iii) transplant factors (pre-emptive
transplantation, number of human leukocyte antigen (HLA)
mismatches); (iiii) acute rejection, defined as renal biopsy-
proven acute rejection (BPAR) or as non-BPAR, being an
acute rejection treatment episode without BPAR according
to Banff 2015 criteria [23].
Renal scintigraphy
All included patients underwent renal scintigraphy for the
analysis of DGF, discerning possible acute tubular necrosis
from vascular or urological complications. In our center, a
second renal scintigraphy was performed in case of ongoing
DGF or suspicion of vascular/urological complications. Renal
scintigraphies were performed using a bolus intravenous in-
jection of 100 MBq Tc-99m MAG3. Two-phase digital dy-
namic images were obtained and processed using Syngo.via
(Siemens Healthineers): (i) 1-s frames for 2 min; (ii) 20-s
frames for 28 min. To calculate the renal scintigraphy time-
activity curves, renal transplant regions-of-interest (ROIs)
were drawn manually surrounding the renal transplant and
the background ROIs were drawn crescent-shaped, opposite
of the renal vessels. The analysis of the renal scintigraphy data
was performed blinded to all clinical variables by a single
researcher.
Qualitative analysis of the time-activity curves was per-
formed using a four-curve type differentiation (Fig. 1 and
Supplement Fig. 1A and B), with a normal renal function with
fast uptake and excretion (grade 1), a normal uptake with flat
excretion curve (grade 2), a rising curve without excretion
phase (grade 3), and a reduced absolute uptake without excre-
tion phase (grade 4). Furthermore, renal scintigraphy results
were stratified into four groups, namely peri-transplant fluid
collections, vascular complications, urological complications,
and no complications.
Quantitative analysis was performed using four indices
reflecting renal perfusion, reabsorption, and excretion. The
tubular function slope (TFS) is a linear fit of the Tc-99m
MAG3 curve between 50 and 110 s, reflecting the tracer up-
take by renal tubular cells (counts/s) [13, 24].MUC10 reflects
the uptake within the first 10 min, as a fraction of the injected
dose (counts/s/MBq) [19]. The corrected tubular extraction
rate (cTER) is the tracer uptake between procedure start and
2 min, corrected for the body surface (mL/min/1.73 m2) [17].
The average upslope reflecting the curve during the upslope
period (counts at 3 min − counts at 20 s)/160 s, in counts/s)
[21].
Statistical analysis
Baseline descriptive statistics and clinical characteristics are
presented as mean ± SD or median (range) for continuous
variables and counts with percentages for categorical vari-
ables. The Mann-Whitney test and one-way ANOVA were
used to describe the variance of continuous variables between
groups. Two-sided p values of less than 0.05 were considered
to indicate statistical significance. Correlations were assessed
by means of Pearson’s or Spearman’s analysis. Univariate and
multivariate Cox proportional hazards analysis and the
Kaplan-Meier curveswith log-rank tests were used to examine
the associations. The hazard ratios (HRs) and their corre-
sponding 95% confidence intervals (CIs) are reported. The
added value of renal scintigraphy indices was assessed by
examining the change in − 2 log likelihood. We used
Package for the Social Sciences (IBM© SPSS Statistics© ver-
sion 22) for all statistical analyses and GraphPad Prism, ver-
sion 5.04 (GraphPad Software), for graph presentation.
Results
Patient characteristics
Patients’ characteristics of the 200 included patients are
displayed in Table 1. Median age was 52 ± 13 years, 59%
were male, 12% underwent pre-emptive renal transplantation,
and median (IQR) duration of pre-transplant dialysis was 36.4
(14.3–57.3) months. Seventy-four (37%) patients received a
DBD transplant, 94 (47%) a DCD transplant, and 32 (16%) a
living donor transplant. The median (IQR) LOS was 15 (11–
21) days.
For 161 (81%) patients, the indication for the first renal
scintigraphy was a suspected acute tubular necrosis as cause
of DGF. For 39 (19%) patients, the indication was a suspicion
for fluid collections and vascular or urological complications.
Only 3 out of these 39 patients experienced a vascular or
urological complication needing a surgical intervention within
2 weeks after transplantation.
The study population was stratified into four groups, based
on early transplant function, as shown in Table 2. From the
131 patients experiencing either DGF or PNF, 108 patients
underwent a second renal scintigraphy within 7 days after
transplantation (Fig. 2).
Qualitative grades and DGF duration
The qualitative grades of the first renal scintigraphy did sig-
nificantly (p < 0.01) differ between the groups of early graft
dysfunction. DGF was observed in 75 (81%) out of 93 pa-
tients with grade 3 and in 35 (85%) out 41 patients with grade
4, while IGF was noticed in 16 (88%) out of 18 patients with
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grade 1 and in 19 (40%) out of 48 patients with grade 2
(Supplement Table 1).
The Kaplan-Meier curves (Fig. 3) for the duration of DGF
and qualitative grading of the first and second renal scintigra-
phy showed a significant difference in DGF duration between
grade 2, grade 3, and grade 4 (p < 0.01) and between grade 3
and grade 4 (p < 0.01), respectively. The Kaplan-Meier curve
for delta qualitative grades between the first and second renal
scintigraphies did not show significant differences between
grades (p = 0.18).
Using the univariate Cox proportional hazards analysis,
qualitative grades of both the first and second renal scintigra-
phies were significantly associated with the DGF duration.
The delta qualitative grades between the first and second renal
scintigraphies were not significantly associated with the dura-
tion of DGF (Table 4).
Based on the qualitative grades, the anticipated moment of
DGF endingwas calculated in a subset of patients without IGF
(Table 3): grades 1 and 2 of the first renal scintigraphy corre-
spond with a median (IQR) of 5.0 (2.0–7.0) days DGF; grade
3with 7.0 (6.3–10.0) days DGF; grade 4with 11.0 (7.5–19.5)
days DGF. Outcomes corresponding with the qualitative grad-
ing of the second renal scintigraphy are presented in Table 3.
Quantitative indices and DGF duration
Quantitative indices TFS, cTER, and average upslope of the
first renal scintigraphy were significantly different between
IGF and SGF, whereas MUC10 did not show a significant
difference. All indices were significantly different between
SGF and DGF, whereas no significant difference was ob-
served between DGF and PNF (Supplement Table 1 and
Supplement Fig. 2).
For the first renal scintigraphy, there was a significant asso-
ciation between the quantitative indices and DGF duration:
TFS, r = − 0.44, p < 0.01; MUC10, − 0.46, p < 0.01; cTER,
− 0.44, p < 0.01; average upslope, − 0.45, p < 0.01. The analy-
sis of the second renal scintigraphy showed a weaker, but still
significant association between the quantitative indices and
DGF duration: TFS, r = − 0.32, p = 0.01; MUC10, − 0.30, p =
0.02; cTER, − 0.32, p = 0.01; average upslope, − 0.33, p = 0.01.
The analysis of the delta quantitative indices between the first
and second renal scintigraphies showed an even weaker asso-
ciation: TFS, r = − 0.24, p = 0.01; MUC10, − 0.26, p < 0.01;
cTER, − 0.24, p = 0.01; average upslope, − 0.25, p = 0.01.
Using the univariate Cox proportional hazards analysis, the
quantitative indices of both the first and second renal scintigra-
phies were significantly associated with the duration of DGF.
The deltas of the quantitative indices TFS and cTER, between
the first and second renal scintigraphies, were significantly as-
sociated with the duration of DGF, HR 0.4 (0.4–0.8, p < 0.01)





Fig. 1 Qualitative renal
scintigraphy grading: grade 1, a
normal renal function with fast
uptake and excretion; grade 2, a
normal uptake with flat excretion
curve; grade 3, a rising curve
without excretion phase; grade 4,
a reduced absolute uptake without
excretion phase [21]
Table 1 Patient characteristics
Variable Patients (n = 200)
Male 116 (59)
Age, yearsb 55 ± 13
BMIb 26.6 ± 3.7
Pre-emptive Txa 24 (12)
Duration pre-Tx dialysis, months c 36.4 (14.3–57.3)
Type of donation
Living (un)related 32 (16)
DBD 74 (37)
DCD 94 (47)
DGF > 7 days after Txa 131 (66)
Length of hospital stay (days)c 15 (11–21)
Rejectiona
7 days after Tx 22 (11)
14 years after Tx 37 (18.5)
Tx kidney transplantation, DGF delayed graft function, DBD donation
after brain death, DCD donation after circulatory death
a n (%)
bMean ± standard deviation (SD)
cMedian (IQR)
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Qualitative grades and length of hospital stay
Using the univariate Cox proportional hazards analysis, qual-
itative grades of the first renal scintigraphy were significantly
associated with LOS (Supplement Table 3). Based on the
qualitative grades, the anticipated LOS was calculated
(Table 3): grades 1 and 2 of the first renal scintigraphy corre-
spond with a median (IQR) of 11.0 (12.0–19.0) days of hos-
pitalization; grade 3 with 15.0 (12.0–19.0) days of hospitali-
zation; grade 4 with 20.0 (14.0–28.5) days of hospitalization.
Outcomes corresponding with the qualitative grading of the
second renal scintigraphy and the delta between the first and
second renal scintigraphies are presented in Table 3.
Quantitative indices and length of hospital stay
For the first renal scintigraphy, there was a significant, how-
ever, weak correlation between LOS and the quantitative in-
dices: TFS, r = − 0.23, p < 0.01; MUC10, − 0.28, p < 0.01;
cTER, − 0.23, p < 0.01; average upslope, − 0.19, p < 0.01.
The analysis of the second renal scintigraphy also showed a
weak but significant correlation between LOS and the quan-
titative indices: TFS, r = − 0.24, p = 0.02; MUC10, − 0.26,
p < 0.01; cTER, − 0.24, p = 0.02; average upslope, − 0.23,
p = 0.02. Using the univariate Cox proportional hazards anal-
ysis, the quantitative indices (TFS,MUC10, and cTER) of the
first renal scintigraphy were significantly associated with LOS
(Supplement Table 3).
Multivariate analysis
Covariates with a significant association with DGFwere DCD
donation, HR 1.9 (1.4–2.5, p < 0.01); pre-emptive transplan-
tation, HR 0.5 (0.3–0.7, p < 0.01); and duration of pre-
transplant dialysis, HR 1.1 (1.0–1.1, p < 0.01) (Supplement
Table 3). The clinical covariates recipient gender, recipient
age, recipient BMI, pre-transplantation diabetes mellitus, do-
nor age, and HLA mismatches did not contribute to a signif-
icant hazard ratio (Supplement Table 2). Outcomes corre-
sponding with the LOS are presented in Supplement Table 2.
In a multivariate analysis, including all other quantitative
indices, the qualitative grading scale, and the clinical covari-
ates, the association between the qualitative grading of the first
renal scintigraphy and the duration of DGF was significant for
grade 3, HR 2.3 (1.3–4.2, p < 0.01), and grade 4, HR 3.4 (1.7–
7.1, p < 0.01). The association between the qualitative grading
of the second renal scintigraphy and the duration of DGF was
significant for grade 4, HR 4.1 (1.9–8.8, p < 0.01) (Table 4).
Table 2 Early graft function for
different types of kidney donation Early graft function
IGF (n = 39) SGF (n = 30) DGF (125) PNF (n = 6)
Type of donation
Living (un)related 20 (63%) 2 (6%) 7 (22%) 3 (9%)
DBD 16 (22%) 16 (22%) 41 (55%) 1 (1%)
DCD 3 (3%) 12 (13%) 77 (82%) 2 (2%)
IGF immediate graft function, SGF slow graft function,DGF delayed graft function, PNF primary non-function,
DBD donation after brain death, DCD donation after circulatory death
200 patients underwent a first RS 
within 3 days after KTX
108 patients underwent a second RS
within 7 days after KTX
IGF (39) or SGF (30) was seen 
in 69 patients
DGF (125) or PNF (6) was seen 
in 131 patients
No further RS procedures were 
performed
In 12 cases, a second RS was 
performed > 7 days after KTX.
In 11 cases, a second RS was 
not performed for unknown 
reasons.
Fig. 2 Flowchart of the included patients
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In a multivariate analysis, including all other quantitative
indices, the qualitative grading scale, and the clinical covari-
ates, the association between the qualitative grading of the first
renal scintigraphy and LOS was HR 1.3 (1.0–1.6, p = 0.04).
Multivariate analysis of the quantitative indices, the qualita-
tive grading scale of the second renal scintigraphy, and LOS
did not result in significant associations (Supplement Table 2).
Predictive performance of qualitative grades
for the duration of DGF
When assessing the predictive performance of the clinical var-
iables, the − 2 log likelihood improved significantly when
including the qualitative grades from the first renal scintigra-
phy (1623.6 to 1583.7, p < 0.01). The predictive performance
of the model with clinical variables did not show a significant
improvement after including the qualitative grades of the sec-
ond renal scintigraphy (766.0 to 737.9, p < 0.01).
Discussion
Our analysis of Tc-99m MAG3 renal scintigraphy indicates
that qualitative grades of two separately analyzed procedures,
at ≤ 3 and ≤ 7 days after transplantation respectively, are sig-
nificantly associated with DGF duration and the LOS.
However, the delta of qualitative grades and the changes of
quantitative indices between these sequential performed renal
scintigraphies are not associated with the duration of DGF and
the LOS. These findings underline the strength of the qualita-
tive analysis of a single renal scintigraphy for the prediction of
DGF duration and LOS. Conversely, there is no additional
value of performing repetitive renal scintigraphy procedures
to assess DGF and LOS.
Our study confirms the findings of previous studies, which
indicated the applicability of the quantitative indices TFS,
MUC10, cTER and average upslope and of the qualitative
grading with four or six grades for the evaluation of DGF
[12, 13, 17–20]. A previous study, focusing on TFS at 48 h
after transplantation showed the capability of this index to
separate patients with DGF from patients with IGF [13]. In
our study, TFS differed significantly between types of early
transplant function and was associated with a longer duration
of DGF, HR 0.5 (0.4–0.6, p < 0.01) and HR 0.6 (0.4–0.8,
p < 0.01) respectively for the first and second renal scintigra-
phy. For MUC10 from a renal scintigraphy performed within
48 h after transplantation, a previous study showed significant
differences between DGF and non-DGF patients, which is in
line with the results of our analysis, showing a significant
difference in MUC10 values between the SGF and DGF
groups [19]. For cTER from a renal scintigraphy performed
≤ 4 days after transplantation, a previous study showed a sig-
nificant correlation with the period of dialysis dependence
(r = − 0.68, p < 0.01), which is slightly stronger than the cor-
relation found in this study (r = − 0.44, p < 0.01) [17]. In a
previous study, a four-grade index was introduced for renal
Fig. 3 The Kaplan-Meier curves for qualitative grading
Table 3 Duration of delayed graft
function and length of hospital
stay based on qualitative grading
Duration of DGF Length of hospital stay
Patients, n Median IQR Median IQR
First
Grades 1 and 2 30 5.0 2.0–7.0 11.0 12.0–19.0
Grade 3 89 7.0 6.3–10.0 15.0 12.0–19.0
Grade 4 41 11.0 7.5–19.5 20.0 14.0–28.5
Second
Grade 2 25 7.0 7.0–7.5 14.0 12.0–16.5
Grade 3 52 8.0 7.0–10.0 15.0 12.3–19.0
Grade 4 31 15.0 10.0–20.0 22.0 15.8–29.3
Results based on a subset of the included patients, after exclusion of all patients with immediate graft function
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scintigraphy at ≤ 3 days after transplantation, using this four-
grade index, an independent association between a longer du-
ration of DGF and the qualitative grades was shown, HR 1.8
(1.4–2.2, p < 0.01), which is consistent with the results of
studies using both four- and six-grade indices [12, 21].
Although previous studies have described the applicability
of a first renal scintigraphy at ≤ 48 or 62 h after transplanta-
tion, this study is the first comprehensive analysis of a second
renal scintigraphy at ≤ 7 days after transplantation.
Quantitative indices of the second renal scintigraphy were
associated with the duration of DGF, however, not when ad-
justed for clinical covariates. Multivariate analysis of the first
and second renal scintigraphy showed an independent signif-
icant association between the qualitative grades and duration
of DGF, HR 1.8 (1.4–2.2, p < 0.01) and HR 2.8 (1.8–4.3,
p < 0.01), respectively. The delta qualitative grades between
the procedures were not significantly associated with the du-
ration of DGF in multivariate analysis.
The presented results should be evaluated in light of non-
imaging biomarkers for DGF, such as the urinary biomarker
TIMP-2 and neutrophil gelatinase-associated lipocalin
(NGAL). The predictive value of TIMP-2 was assessed in a
population of DCD transplant recipients (n = 74), showing an
area under the curve (AUC) of 0.89 (95% CI 0.78–0.99) for
> 7 days functional DGF [7]. For urinary NGAL, the AUC for
> 7 functional and dialysis-based DGF was 0.75 (95% CI
0.65–0.84) in a population of both DBD and DCD transplant
recipients (n = 176) [8]. Renal scintigraphy, performed within
3 days post-transplantation to predict ≥ 7 functional and
dialysis-based DGF, showed to have an 87% sensitivity and
65% specificity when analyzed qualitatively and an AUC of
0.82 (95% CI 0.78–0.86) when analyzed quantitatively [21].
Further prospective studies are needed to establish the clinical
value of qualitative and quantitative renal scintigraphy analy-
sis in light of emerging non-imaging biomarkers for DGF.
Previous studies focusing on the use of renal scintigraphy
after transplantation did not use LOS as one of the endpoints.
However, this is important since with the increased use of renal
allografts from extended criteria and DCD donors, a prolonged
hospital stay, and subsequent higher transplant-related costs are
reported [4]. In addition, an increased focus on patient-related
outcome measures (PROMS) shows the significance of
informing patients on the clinical path during and after hospi-
talization, urging for a reliable indication of moment of DGF
ending and the LOS. The results of our study are in line with
the literature, with 47% of the transplants coming from DCD
donors, a median length of stay of 15 [11–21] days, and in 66%
of patients a DGF duration of > 7 days, and provide insight in
the expected moment of hospital discharge.
Due to the retrospective design, a clinical selection bias re-
sulted in a cohort of patients with a high incidence of DGF and a
minimal number of patients with IGF, this selection further in-














































































































































































































































































































































































































































































































































































































































































































































































































scintigraphy. On the contrary, the relatively large number of
patients with a sequential renal scintigraphy ≤ 7 days after trans-
plantation contributes to a reliable analysis. Thereby, we per-
formed an extensive multivariate analysis to adjust for possible
confounders, including all qualitative and quantitative scintigra-
phy indices in a single model. Presenting a single-center study
with a small time frame for inclusion, we can expect a unifor-
mity in transplant care and similarity in renal scintigraphy.
Furthermore, analyzing the results quantitatively and qualitative-
ly decreases the impact of inter-observer variability, while our
blinded renal scintigraphy analysis decreases the risk of bias.
Conclusion
In conclusion, a reliable indication of the duration of DGF and
the LOS can be provided by qualitative analysis of single renal
scintigraphy, whereas the qualitative and quantitative change
between sequentially performed renal scintigraphies does not
strengthen the prediction of DGF duration and LOS.
Qualitative grades of single renal scintigraphy can be used to
provide clinicians and patients with a reliable indication of the
need for dialysis after transplantation and the expected duration
of hospitalization, while the additional value of performing a
consecutive renal scintigraphy for the assessment of DGF was
not found.
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